Group One Trading’s Kindred Biosciences, Inc. KIN Stock Holding History

Group One Trading’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,200	Closed	-$20K	–	9109
2021 Q2	$20K	Sell	2,200 -6,100	-73%	-$35.5K	﹤0.01%	7204
2021 Q1	$41K	Buy	+8,300	New	+$40.1K	﹤0.01%	6367
2019 Q1	–	Sell	-100	Closed	-$11K	–	5603
2018 Q4	$11K	Buy	+100	New	+$1.26K	﹤0.01%	4253
2017 Q3	–	Sell	-2,800	Closed	-$24K	–	5341
2017 Q2	$24K	Sell	2,800 -500	-15%	-$3.59K	﹤0.01%	3877
2017 Q1	$23K	Buy	+3,300	New	+$20.7K	﹤0.01%	3827
2015 Q1	–	Sell	-1,300	Closed	-$10K	–	5371
2014 Q4	$10K	Buy	+1,300	New	+$11K	﹤0.01%	4249

Other funds holding KIN

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Group One Trading's KIN Position: Q3 2021 in Review

Group One Trading sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 30,976 shares — an estimated $284K sold.

Group One Trading first reported a position in KIN in Q4 2014 and held it in 10 quarters. The position peaked at $284K in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

Group One Trading reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
Group One Trading sold 30,976 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $284K.
Group One Trading first reported a position in Kindred Biosciences, Inc. in Q4 2014 and held it in 10 quarters.
Group One Trading's Kindred Biosciences, Inc. position peaked at $284K in Q2 2021.
1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Group One Trading's 13F filing for Q3 2021, filed 12 Nov 2021.